Evan Newell is Professor in the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Center. He completed his B.Sc. in Immunology at McGill University and Ph.D. in Physiology at the University of Toronto. He did his post-doc at Stanford with Mark Davis where he worked on biophysical aspects of T cell antigen recognition and initiated the use of mass cytometry for the study of human T cell responses. He started his lab as principal investigator at the Singapore Immunology Network (SIgN) in 2012 and then moved to Fred Hutch in 2018. His lab applies and develops novel experimental and computational approaches for identifying and thoroughly characterizing human antigen-specific T cells. A major goal of the lab is to identify useful biomarkers of clinical outcomes in the context of human vaccines, infectious diseases and cancer.